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CASE SUMMARY
The purpose of this study is to investigate the current
marketing strategy that the Upjohn Pharmaceutical Company
uses to sell its hair treatment product Rogaine. The
researcher also wants to discover why Rogaine is not
receiving acceptance by the consumer. The researcher then
looks at alternative marketing strategies which incorporate
different philosophies that will perhaps increase the sales
of Rogaine. The first marketing strategy alternative advises
Upjohn to use pricing strategies, sales promotions and
advertising that is more specific. The strategy also
suggests mentioning the product name on television
advertisements, along with the risks and side effects.
A second marketing strategy alternative is to start a
joint venture with a men's personal products company that
has marketing knowledge and strong channels of distribution
in the men's personal products industry. A well known
company with a full line of related personal products for
men could be more successful at marketing Rogaine than
Upjohn.
A third alternative would be the abandonment of
Rogaine. The market may be too limited to support the
product in the long run, also, the price may be too high.
Upjohn seems to be closely involved and has no experience
marketing a personal product for men, nor does it have
access to channels of distribution to the men's personal
product industry. Consumers may refuse to comply with the
twice daily application required, and the results are too
poor to encourage the life long use the product requires.
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Introduction
The Upjohn Pharmaceutical Company of Kalamazoo,
Michigan, a 103 year old major manufacturer of
pharmaceutical products, is known to be an innovator in its
field. It recently introduced a new drug in the United
states under the brand name Rogaine. Rogaine is a topical
solution of the drug minoxidil used for the treatment of
hypertension. This solution, when applied to the crown of
select men's heads two times a day, has been shown either to
stop or retard the progression of male pattern baldness.
Rogaine comes in a bottle containing a one month supply,
with a choice of rub-on or spray applicators. The
applicators are designed so that the user gets the correct
dosage, one milliliter per application. Appendix A displays
an example of a one months supply of Rogaine. The user
applies it not only to balding spots, but also to adjacent
areas that might go bald.
The discovery of Rogaine was entirely by accident.
Rogaine contains two percent of the drug minoxidil.
Minoxdil is taken in tablet form for the treatment of
hypertension. Hypertension is defined as an elevated blood
pressure. The side effects of taking minoxldll are hair
growth on some parts of the body, often on the forehead or
on the upper cheeks. As a result of these findings, when the
drug is put in a topical solution and applied to the heads
of select men with hair loss on the crowns of their heads,
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hair growth occurs. Appendix B demonstrates one of the
daily applications of Rogaine. The Upjohn Company finds
that Rogaine either stops or retards hair loss on men who
have male pattern baldness. Rogaine is the only treatment
for hair loss that is approved by the Food and Drug
Administration (FDA). Sales in the United states for
Rogaine are lower than The Upjohn Company anticipated. It
expected $1 billion in sales in the first year. In 1988,
the market returned $48 million in actual first year sales
(Benoit, 1989). The Upjohn Company claims the sales were
based on customers' incomplete understanding of the product,
not on unrealistic expectations of what Rogaine could do.
The Upjohn Company does not market Rogaine as a
personal product for men. The Upjohn Company considers
Rogaine a prescription pharmaceutical that is sold like an
ethical drug through physicians who prescribe it for
patients. The Upjohn Company's sales people are to sell to
doctors via personal calls. The advertising simply urges men
concerned about baldness to consult their doctors. Upjohn
chairman Theodore Cooper, President Lawrence C. Hoff, and
their marketing people think Rogaine should be sold by
advising men who are concerned about hair loss that medical
help is available (Sloan, 1988). This technique is coupled
with traditional marketing to physicians and pharmacists
(Freeman, 1989).
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Background of the Upjohn Pharmaceutical Company
The Upjohn Pharmaceutical Company manufactures
pharmaceutical and agriculture products and provides health
care services in both the United States and in foreign
markets. The firm has research, manufacturing, sales and
distribution facilities in more than 200 locations
worldwide. In mid-1989 the firm employed approximately
20,600 persons, and had approximately 16,000 stockholders
(Upjohn, 1988). About 30 percent of the firm's outstanding
stock was closely held. The owners of the closely held
shares were primarily members of the Upjohn family.
Dr. William Upjohn patented a process for making pills
in 1885. The resulting pills dissolved rapidly once inside
the human body. The process represented a significant '
forward step in medicine because the dosage accuracy was
enhanced. In the following year, he and his brother founded
the Upjohn Pill and Granule Company in Kalamazoo, Michigan.
Medications, such as quinine pills and laxatives,
contributed to the company's early success. In 1913, the
firm established its own research laboratory. From there
Upjohn launched itself into the modern pharmaceutical
market.
The Upjohn Company has traditionally sought and has
been generally successful in attaining high product quality.
Some of the company's products, however, had encountered
problems with both the medical communities and governmental
regulatory bodies in the United states and some foreign
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countries. The firm's problems in the areas of product
quality and consumer liability, however, have been
relatively minor in comparison to those experienced by some
competitors (Eaton, 1989).
The company's major product groups are (one) steroids
and other anti-inflammatory agents, (two) antibiotics, and
(three) central nervous system agents. In terms of total
company sales, steroid products account for 23 percent,
antibiotic products account for 17 percent, and central
nervous system agents account for 14 percent (Upjohn,
1988). A total of 54 percent of the firm's total sales are
accounted for by the three groups (Eaton, 1989).
The company's leading brand name drugs include Lincoln,
Cleocin, Medrol, Unicap, Orinase, Tolinase, Motrin, Halcion,
Xanax, and Rogaine. Not all brands are sold in all markets
in which The Upjohn Company participates (Upjohn, 1988).
Upjohn has given considerable marketing attention to
Rogaine.
The Upjohn Company's management continues a traditional
emphasis on product quality, research, and a pursuit of both
prescription and non-prescription medications. Upjohn's
mission is to advance health through science and medicine.
The company's motto is "Today's research tomorrow's
health." (Upjohn, 1988). The company's research and
development expenditures for the year of 1987 accounted for
14.1 percent of the $2.7 billion of sales experienced in
that year (Eaton, 1989). It was the second highest
investment in research and development in the industry
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(Eaton, 1989). Upjohn concentrates its research and
development in the area of hair treatment. The Company's
long term goal is to be the first to market a drug that has
a noticeable effect on baldness. Rogaine is the first and
only FDA approved treatment for male pattern baldness.
Total sales increased at The Upjohn Company each year
during the 1984-1989 period, from $1.828 billion in 1984 to
$2.987 billion in 1989 (Eaton, 1989). When sales were
adjusted for inflation, as measured by the gross national
product (GNP) deflator, sales growth still occurred but at a
slower rate. This sluggish growth is in spite of the fact
that the company spent $60 million in 1989 on advertising of
Rogaine (Eaton, 1989).
Current Situation
Rogaine opened up a whole new market for Upjohn and the
field of therapeutic research which was known as
cosmeceuticals. Rogaine is a pharmaceutical product for a
cosmetic application. In addition, the product presents
unusual marketing challenges because it is a prescription
drug approved for a non - pathological condition, hair loss.
Upjohn's management placed emphasis on Rogaine in the
1970's. The discovery of minoxidil began during the mid-
1960's, when Upjohn researchers studied antacid compounds
and discovered that one, called minoxidil, reduced the heart
rate of laboratory animals. In 1968 the company registered
minoxidil with the FDA as an experimental new anti-
hypertension drug for humans, and won approval for the
treatment of hypertension in 1979 (Levine, 1988).
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Meanwhile, Upjohn researchers had noticed that quite a
few participants in the minoxidil tests for cardiac use had
shown hair growth, usually on the forehead or upper cheek.
When one bald patient developed new hair on the top of his
head in 1973, Upjohn began to believe it had finally
produced a cure for male pattern baldness (Smith, 1986).
Clinical testing began in 1977, and by 1982 a two percent
minoxidil solution was prepared. Two factors determined the
complexity and scope of clinical trials with minoxidil.
First, no drug had ever been tested on hair growth before.
Second, it was a potent drug that was to be used for long
periods of time for the treatment of baldness, a non-
pathological condition. A large number of patients had to
be enrolled in the trials. Minoxidil was tested on more
than 4,000 men in clinical trials and related studies
(Upjohn, 1988). The primary efficacy trials covered 2,326
men at 27 sites around the United States (McGinn, 1987).
Dose range finding studies determined that a two percent
solution offered the best safety and efficacy profile.
Results showed that minoxidil did in fact stop or retard the
progression of male pattern baldness. Those results are
supported by a significant number of participants which
reinforced Upjohn's 1985 application for approval to the FDA
(Rhein, 1987).
Through the long development, and especially after
efficacy tests were submitted to the FDA in 1982, Rogaine
captured the enthusiastic attention of the press. Wall
street reacted by bidding up Upjohn's shares from $22 to $54
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during the first nine months of 1987, three times the
market's overall rate of increase (Lazo, 1988). When
Rogaine was approved by the FDA in August of 1988, Upjohn
paused nearly two months to train its sales force about the
product. Then in October of 1988, it began marketing to the
medical community with advertising in medical journals and
sales calls of pharmaceutical sales representatives. The
original timetable did not call for consumer advertising to
begin until January or February of 1989. Internal pressures
prompted Upjohn to run the first advertising in late
November of 1989. Upjohn felt it could not begin marketing
Rogaine to consumers until it felt the awareness level was
adequate in the medical community (Benoit, 1989).
When the consumer advertising began, Upjohn chose a
soft sell approach. The television advertisement showed a
balding man walking along a beach with his dog, wondering
what he should do about his thinning hair. The
advertisement urged him to consult his physician for advice,
but never mentioned Rogaine. Federal law prohibits Upjohn
from mentioning the brand name Rogaine on the television
advertisements because it is an ethical drug and the
advertisements did not mention the risks and side effects of
the product. Upjohn wanted to get the patients into the
doctor's office and let the physicians do the rest. People
who are not actually sick needed a powerful inducement to
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visit their doctor. As a result, in the first quarter of
1989 Rogaine was selling at the rate of only $4 million a
month in the United states (Eaton, 1989).
After disappointing sales results, the company revised
the soft sell television advertising campaign. It tried a
more suggestive approach featuring a balding man standing
agape before his bathroom mirror contemplating what hair
treatment he could use to help slow the balding process.
The message at the end of the advertisement suggested that
if you were interested in learning more about reducing hair
loss call the toll free number shown. A trained hair
consultant would send further information and would give
names of physicians in the area that were familiar with the
hair treatment that was available through the Upjohn
Company. The toll free number was used to help reduce the
embarrassment men felt about inquiring about help for their
hair loss (Freeman, 1989b).
Actual sales results were still poor which prompted
Upjohn to change its advertising campaign again.
Advertising in newspapers and magazines appeared in August
1989 and urged people to ask their doctor to prescribe
Rogaine. For the first time the risks and side effects were
listed, as well as the Rogaine brand name. Upjohn started
to sell Rogaine as a consumer product. Regaine was the brand
name used when Upjohn began selling the product in other
countries such as Canada in 1986. Upjohn felt the Regaine
name implied a promise of total efficacy. The philosophy the
company has regarding customer satisfaction combined with
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the strict laws in the United states caused it to change the
name to Rogaine in the United states (Freeman, 1989c).
Identification of the Marketing Problem
There are many reasons for Rogaine's sluggish sales.
First, both the price and dosage are more than what the
consumer will tolerate. The price is about $50 for a one
month supply. The dosage requires lifelong commitment to its
use. Once the use of Rogaine is stopped, any hair that has
grown back will fallout.
Second, Upjohn's $60 million television advertising
campaign, featuring a balding man walking along a beach with
the "see your doctor" phrase, may be too low key and vague.
Upjohn chose to take this approach because federal law
requires that if a drug name is mentioned in an
advertisement, side effects from the drug must be mentioned.
Upjohn fears that mentioning side effects of Rogaine would
discourage potential customers from trying it. The problem
with the advertisements could be that the viewer does not
know if the available treatment 1s a hair weave, a
transplant, or a drug. Some consumers are not aware of the
product nor its attributes. Awareness is measured through
two levels, unaided and aided. Unaided product awareness
involves consumers recalling specific product names without
any assistance. Aided awareness is the awareness generated
by asking individuals which product they are familiar with
after reading or reviewing with them a list of competing
products (Hiebing and Cooper, 1990). Unaided awareness is
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not possible because Rogaine is a new product in the new
industry of cosmaceuticals. Aided awareness is not possible
because Rogaine has no competitors.
Third, a man has to go to the doctor and admit that he
is not comfortable with his hair loss. The cost of an
office visit to a physician for cosmetic hair loss is not
covered by insurance. This cost combined with the
uncomfortable nature of the visit may cause potential
customers to hesitate trying Rogaine.
Fourth, Upjohn, the pharmaceutical company that
presents the product, may be just another corporate name to
the consumer. It does not have a reputation of being
affiliated with men's personal products. It has experience
marketing pharmaceutical products directly to the health
care market. It does not have experience marketing personal
products for men to the consumer market. Upjohn may have
the impression that it has finally found a cure for male
pattern baldness even though the results of Rogaine and the
market for potential users may be limited. Upjohn continues
to invest heavily in the marketing of Rogaine.
Fifth, the bad reputation of hair treatments may
contribute to the sluggish sales of Rogaine. Hair potions
have been around for centuries claiming to restore a full
head of hair in just one treatment. This may cause
consumers to be hesitant to purchase Rogaine.
Finally, and most importantly, long term research
lasting ten years or more has not been conducted to
determine if there is a market that will support the life
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long usage Rogaine requires. The reason why research
lasting ten years or more is needed is because results from
the product take time. Even though Rogaine was discovered
in 1973 and attained FDA approval in 1988, it has not been
in the market long enough to provide long term results. The
risks and side effects also take time to attain and to
evaluate.
Analysis of the Market for Hair Treatments
Nationally According to the American Demographics
Institute, the 52,000,000 baby boomers of the United states
continue to age and their income levels continue to rise.
(Butenhoff, 1988). What this means to Upjohn is that the
target audience for Rogaine will continue to grow.
According to Ronald Nordman, a research analyst with Paine
Webber, Incorporated, the target audience for Rogaine is the
middle aged man between the ages of 25 and 44. The annual
income of this target audience is $35,000 or more. The
members of the Upjohn target market are better educated,
active people in good health and, perhaps most importantly,
are people with a considerable amount of net disposable
income.
A total of SO million Americans, 30 million men and 20
million women, or nearly two out of every three individuals
develop some form of baldness. (Castleman, 1986). With the
exception of legitimate hair transplants, the FDA passed a
law in the summer of 1988 that banned any treatment or
12
nonprescription product in the United states that claimed to
restore, thicken or grow hair on balding heads (Folkenberg,
1988). Rogaine is the only hair treatment with the FDA
approval either to stop or to retard the progression of male
pattern baldness. The challenge that faces Upjohn is to
market Rogaine properly to this ever growing market.
Local Market The local market was explored in order
to investigate the possibilities of Upjohn marketing Rogaine
in Milwaukee County. The researcher surveyed dermatologists
and family practitioners via mail surveys. The general
pUblic of men who showed baldness was surveyed via street
interviews in Milwaukee County. Appendix C and Dare
examples of the questionnaires that were used in the market
research. The response to the Milwaukee County survey was
low thus the results are not conclusive.
A questionnaire is a series of predetermined questions
that can be either self-administered, administered by mail,
or asked by interviewers. The researcher chose to survey
the population of dermatologists and general practitioners
in Milwaukee County by mail. The general public of men in
Milwaukee County who showed hair loss was surveyed by the
researcher in a sidewalk interview. Some surveys are
uniquely suited to mail, whereas others are more
appropriately conducted by interview.
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Mail surveys and interviews each have unique advantages
and limitations. The advantages and disadvantages of each
are discussed in the following paragraphs. The choice of
which method to use in a particular situation should be made
by considering the overall nature of the survey.
The first factor to be considered when conducting a
surv~y is how much money, time, and personnel do you have at
your disposal. Almost always, in-person interviewing is
more expensive than either telephone interviewing or the use
of mail surveys. This is especially true in cases where the
sample size is large and/or spread out over a wide
geographic area. The need to pay for travel time associated
with in-person interviewing is the main reason for cost
disparity (Sudman and Bradburn, 1982). Since the market to
be surveyed was Milwaukee County, and the population of
dermatologists and general practitioners was small, the
researcher choose to survey the physicians via mail. The
mail survey of the physicians worked well because it was
difficult to determine when the physicians had free time to
be interviewed. The mail survey can be completed at the
convenience of the respondent 1n an environment of their
choosing. Mail surveys also allow people the time to search
through records to find information needed to answer the
questions (Berdie and Anderson, 1986).
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The stimulus presented by a mail questionnaire is the
same from respondent to respondent. The interviewer is
removed as a possible bias. However, if the questionnaire
format of a mail survey is poorly constructed, it will be
interpreted differently by different respondents, leading to
biased responses (Budman and Bradburn, 1982).
Hailed self-complete survey formats are easy to execute
to physicians because they are accustomed to being surveyed
by drug and medical equipment companies. Unless the
physicians have received so many mail surveys that they
resent them, the use of mail works well with physicians.
Although some physicians who receive many mail
questionnaires have come to loathe them, researchers have
found this is usually because they have received many poorly
designed mail questionnaires (Sudman and Bradburn 1982).
The key to conducting a good survey is to use a
technique that people understand, which usually means with
which they are familiar. The technique must be used in a
manner that makes it easy for people to respond (Berdie and
Anderson, 1986). The researcher used a combination of open
and closed ended questions. The opened ended questions
allowed the physicians to express their opinions. Closed
ended questions allowed quick responses so the survey did
not take much time to complete. The questions the
researcher asked were short, attention getting, and used
simple language. The researcher included a stamped, self
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addressed envelope with the survey so that it would be easy
for the physician to send it back. Some types of question
formats are uniquely suited to mail surveys, whereas other
types only work well with interviews (Berdie and Anderson,
1986 ) . Rating scales that require people to rate items are
more versatile in mail surveys than they are in interviews
(Berdie and Anderson, 1986). It is quite easy to ask people
in a mail survey whether they are "very satisfied,"
"satisfied," "neither satisfied nor dissatisfied,"
"dissatisfied," or "very dissatisfied" with a series of
issues about which you might ask. This use of the five
response options works well with mail surveys because the
respondent can see the options and, therefore, keep them
mentally present (Berdie and Anderson, 1986). The
researcher used a scale from one (disapprove) to ten
(approve) in the mail survey to the physicians. In an
interview, however, after a few questions, respondents are
likely to remember only "satisfied," and "dissatisfied."
Although they may feel quite strongly about a given
response, they are not likely to respond appropriately.
Therefore, mail questionnaires work best if it is necessary
to use many response options (Berdie and Anderson, 1986).
Some people are offended by the lack of personal
contact. To them, mail questionnaires exemplify
impersonality. A thorough familiarity with the types of
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people you wish to survey will indicate whether mail
questionnaires will be problematic in this regard.
There is an uncertainty about who completed a returned
mail questionnaire. At times, the questionnaire recipient
may forward the questionnaire to a person believed to be
more qualified. Sometimes the issue of who completes the
questionnaire may be of prime importance. In such cases, in-
person interviews are usually preferable to mail surveys.
Unless a respondent is highly motivated to respond, the
.quality of a telephone interview starts to deteriorate
qUickly (Berdie and Anderson, 1986). Surveys requiring an
abundant number of questions should be conducted either by
mail or by in-person interview. A respondent can complete a
mail questionnaire more quickly than an in-person interview
that contains the same number of questions (Berdie and
Anderson, 1986). This is because people read faster than
they can listen.
Given the cost savings of mail surveys over in-person
interviews, and given the fact that respondents can answer a
lot of mail survey questionnaires in a short period of time,
mail surveys are an excellent technique to use when many
questions need to be asked. This does not mean that the
mail survey should be overly long. Seemingly more important
than length 1s question content. People do not like to be
asked irrelevant, uninteresting questions. Rather than
trying to keep questionnaire items short at all costs,
17
questionnaire items should be interesting to the respondent,
relevant to the purpose of the study, and limited to
absolutely essential items (Berdie and Anderson, 1986).
The study topic affects which data collection technique
should be used. Topic areas that are sensitive to
respondents are especially important to consider. Baldness
is a sensitive issue. An in-person interview is appropriate
because personal contact allows the interviewer to be more
considerate and empathic. In-person interviews also allowed
the researcher to observe the extent of baldness a man had
to determine if he would be a candidate for Rogaine.
The researcher conducted a sidewalk survey of the
general public of men in Milwaukee County who showed hair
loss. The response to the survey was low thus the results
are not conclusive. The sidewalk survey was done because
nearly two out of every three men develop some form of
baldness, and the researcher was the only one available to
conduct the survey (Castleman, 1986). Thus, the
probability of meeting men on the sidewalk who show baldness
was high.
Interviewer bias plays a part in a personal interview.
Interviewer variability refers to the different voice
inflections, pronunciations, mannerisms, and gestures that
are used by the interviewer during the interview (Berdie
and Anderson, 1986). This variability can affect the
responses given to survey questions, especially if the
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respondent is more concerned with pleasing the interviewer
than with giving accurate responses. Interviewer
variability is an especially serious problem in large
surveys that require many interviews. Even with careful
training and monitoring, it is hard to insure consistent
presentation of survey questions in these large surveys.
Interviews work more effectively than mail surveys when
recall and recognition questions are linked together. This
type of questioning does not work well in a mail survey
because people may review the specific factors before they
answer. Their review may influence their answer to the
question. Interviews are not susceptible to this problem
because the interviewer controls the order 1n which the
questions are presented to the respondents (Berdie and
Anderson, 1986).
Some questions may require people to look at physical
objects as part of the survey. The object to be examined
can sometimes be sent along with a mail survey. It Is
usually less cumbersome and more effective to conduct these
types of studies by in-person interviews.
Mail Survey
The researcher conducted a mail survey of physicians
that consisted of a total population of 37 dermatologists
and 95 general practitioners in Milwaukee County. This
population is according to the 1985 u.s. Department of
Commerce Bureau of the Census and the Metropolitan Milwaukee
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Economic Fact Book which is put out by the Wisconsin
Department of Administration. The researcher mailed
questionnaires to all of the 132 physicians and received
back 35 of the questionnaires, a 27 percent response. Given
the fact that the response to the survey was low the results
are not conclusive.
All of the physicians that responded to the survey were
aware of Rogaine. The researcher used a scale from one to
ten, one rating extreme dissatisfaction and ten rating
extreme satisfaction with the results of Rogaine. The
doctors that responded to the survey were asked to rate the
effectiveness of Rogaine verses other alternatives. Fifteen
of the respondents (eleven percent of total surveyed, 43
percent of respondents) had a negative overall impression of
Rogaine. Nineteen of the respondents (58 percent) had a
positive overall impression of Rogaine. Appendix E
graphically illustrates the impression the physicians that
responded to the survey had about Rogaine. The trend that
Appendix E illustrates is that more physicians have a
tendency to disapprove of Rogaine. If this tendency
continues physicians may not write as many prescriptions for
Rogaine and the product may not sell well. Upjohn may either
need to concentrate efforts on selling Rogaine that is
currently available to physicians or greatly improve the
product so physicians will feel that it is safe to write
prescriptions for Rogaine for a larger group of people.
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All of the physicians that responded to the survey had
recommended Rogaine to some patients because: patients were
requesting it; it was the only hair treatment that was FDA
approved to slow male pattern baldness; there were no other
pharmaceutical treatments like it, and the physicians and
patients were pleased with the results. The reasons why the
physicians did not recommend Rogaine included: it was too
expensive; the results were unpredictable; the product had
too long a dosage time; the results were negligible; the
patient was too old; there was not enough long term follow
up, and it showed no permanent hair gain.
The physicians that responded to the survey reported
more of an increase in patient requests for Rogaine than a
decrease as a result of the patient seeing advertising on
Rogaine. Seventy percent of the respondents indicated an
increase in patient interest. Thirty percent indicated a
decrease in patient interest. Appendix F graphically
illustrates that more men in Milwaukee County are coming to
physicians as a result of seeing advertising on Rogaine. The
advertising is catching the attention of men who are
concerned about reducing baldness. As previously discussed
in Appendix E physicians disapprove of Rogaine and are not
writing as many prescriptions as possible. The survey
indicated that there were 1,999 patients of the doctors that
responded to the survey in Milwaukee County who were current
users of Rogaine.
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All of the physicians that responded to the survey
indicated that the risks of using Rogaine for a continuous
long term period were low. The results of the usage were
also limited. Sixty-nine percent of the respondents rated
the results as poor. Price, compliance with twice daily
requirement applications by the patient, and results were
the main areas which concerned the physicians in the
Milwaukee County survey.
Sidewalk Survey
The researcher approached 200 men who showed hair loss
in a sidewalk survey in Milwaukee County to further analyze
the local market of Rogaine. The researcher received
responses that completed the survey from 81 of the 200 men
contacted (41 percent response). Eleven men (six percent)
started to respond to the survey but did not complete it.
They were considered to be part of the total respondents.
The aggregate of respondents was 92 (46 percent response).
Non-respondents (53 percent) were counted as part of the
total population. The response to the survey was low thus
the results are not conclusive. The average age of those
contacted was 32. Appendix G illustrates the relation
between the men that responded to the survey who would use
Rogaine and age. Of those who were between the ages of 20
and 29 (12 in group) 67 percent indicated that they would
use Rogaine. Thirty-three percent of those in this age
bracket indicated they would not use Rogaine. Of those who
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were between the ages of 30 and 40 (64 in group) 73 percent
indicated that they would use Rogaine. Twenty-seven percent
of those in this age bracket indicated they would not use
Rogaine. Of those who were over the age of 40 (five in
group) 80 percent indicated that they would use Rogaine.
Twenty percent of those in this age bracket indicated they
would not use Rogaine. The trend Appendix G shows is that
the target market for Rogaine is men between the ages of 30
and 40. Forty-four percent of the respondents were married.
Appendix H illustrates the relation between the men that
responded to the survey that use Rogaine and marital status.
Fifty-eight percent of the respondents who would use Rogaine
were single. Seventy-nine percent of the respondents who
would use Rogaine were married. This illustrates that
marital status influences those who would use Rogaine.
Marketing efforts should be directed towards the married
man. Of the respondents, 66 percent indicated that they had
considered treatment for hair loss and 72 percent indicated
they were interested in stopping their loss of hair.
Eighty-eight percent indicated they saw the television
advertisement. Sixty-one percent of the respondents were
familiar with Rogaine through television advertisements.
The respondents felt the advertisements were vague, eye
catching, and cute. All of the respondents felt the
advertisements should be more specific. A majority of the
respondents also felt that the advertisements should be
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affiliated with a company that sells personal products for
men and mentions the product name and what the product can
do. Seventeen percent of the respondents indicated they
knew someone who was using Rogaine besides themselves and
they learned of Rogaine through referral. The same
respondents indicated that the treatment was slow,
expensive, and it was hard to comply with the twice daily
application. Overall, the respondents suggested that
Rogaine should show more results and be priced lower .
.According to the respondents, more promotions would give
them reason to continue treatment.
Alternative Procedures to Reduce Baldness
Alternative procedures to reduce or cover baldness
include wearing a wig or toupee, anteroplasticy,
galeoplasty, and hair weaving. There are a number of
temporary and permanent methods for disguising or replacing
lost hair. A temporary means of disguising hair loss is the
wig or toupee. Many kinds of hairpieces are available, and
some of them are attached to the scalp by adhesives. The
effectiveness of hairpieces depend largely on the skills of
those who design them and how they are worn.
There are three permanent means of replacing hair loss.
The first is known as anteroplasty. In anteroplasty, plugs
of hair are surgically implanted in balding areas.
Galeoplasty is a second method of replacing hair loss.
Balding skin is surgically removed from the top of the head.
Then, hair covered skin from the back of the head and from
the sides is stretched upward (Freifeld, 1986).
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A third method, hair weaving, is also available. This
process inyolves tightly stretching the balding person's own
hair across the head. Real or synthetic hair is attached to
and anchored by the patient's own hair. Most dermatologists
do not recommend this practice, however. Hair weaving makes
thorough cleaning of the scalp and hair difficult
(Freifeld, 1986).
There are disadvantages to each alternative procedure
to reduce or cover baldness. The disadvantages of wigs or
toupees are that they do not look natural and have the
possibility of blow1ng off one's head. Another disadvantage
of wigs and toupees is that they cannot be worn while
swimming.
Anteroplasty involves a series of operations. The
procedure is not covered by medical insurance, it costs as
much as $15,000, and it requires a year or two to complete
(Price, 1989). Despite the time and expense, an estimated
250,000 American men each year elect to have the surgery.
Hair transplanted from the back or side of the head
could continue to grow as it would at its original site.
Hair transplant surgery requires a series of visits for
treatment. The doctor begins by injecting a local
anesthetic into the areas where the surgery will take place.
Then a circular punch is used to remove tiny pieces of
scalp, each containing about eight to 15 hair follicles
(Price, 1989). The hair follicles are placed in spots on
the bald scalp that are cut with a similar instrument. The
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donor sites are closed with stitches, while the area that
receives the transplant is bandaged for a day.
The grafts are to be spaced far enough apart to insure
adequate nourishment from surrounding blood vessels. That
is the reason why transplants are done in stages. The first
stage of a transplant includes 30 grafts. There must be at
least a three week wait for the next transplant to occur
(Price, 1989).
Galeoplasty decreases the area of the bald scalp that
the transplants have to fill. A strip of skin is cut out of
the bald area and the edges of the scalp are sewn together,
which moves the hair on the sides of the head closer to the
top. A scalp reduction procedure often costs $1,500 to
$2,000 (Folkenberg, 1988).
The side effects from the surgery are relatively minor.
Overnight pain and temporary swelling might appear after a
day. A sensation of numbness that could last for weeks or
months until nerve endings regrow is expected with
galeoplasty. Extraction of the scalp plugs leaves faint
scars. If the procedure is done correctly, the scars will
be hidden by the remaining hair. Hore serious but rarer
side effects include post operative bleeding, which may
require additional stitches, and infection which is treated
with antibiotics (Folkenberg, 1988).
There could also be a psychological burden from
galeoplasty. If the bald area is large the healing and hair
growing process may be visible. There is considerable
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debate among dermatologists about whether hair transplants
offer enough cosmetic improvement to be worth the time,
cost, risk, and discomfort.
A major problem with hair transplants is finding a
surgeon who could produce good cosmetic results. There are
many different surgical techniques for hair transplants.
The risk of finding a surgeon with poor skills and
controversial techniques is great (Freidfeld, 1986).
Description of Potential Solutions
The Upjohn Company faces slow sales of Rogaine. The
current marketing strategy of Rogaine may have to change in
order to increase awareness of the product and ultimately,
sales.
There are at least three alternatives for the company
to consider:
1. Use pricing strategies, sales incentives, and better
advertising. The advertising could be more specific and
possibly mention the product name on television
advertisements along with the risks and side effects.
2. Starting a joint venture with a company with more
consumer marketing knowledge than ,Upjohn. Upjohn needs a
company with a name consumers know for haVing a full lineup
of related personal products for men. The company should
have strong channels of distribution for personal products
for men. This could help Upjohn market Rogaine better.
3. Abandonment of Rogaine altogether because there may
not be a strong market to support the product in the long
term. Some current users may refuse to comply with twice
27
daily application requirements. The price is too high and
results too poor to encourage life long use. Upjohn may be
too involved with the product. The company has no experience
marketing a personal product for men nor does it have access
to channels of distribution to the men's personal product
industry.
Alternative One - Pricing strategies, Sales Promotions,
and Advertising The determination of pricing strategies for
Rogaine is of major importance to marketing managers at
Upjohn. Usually the company that first introduces a product
has the freedom to set the price it desires. The pricing
decision is often a function of the company's ability to
produce the product, product availability, and the amount of
anticipated competition. Through pricing, management
attempts to recover the costs of the separate elements in
the marketing mix. The marketing mix includes the product
itself, associated adverti~ing, personal selling expenses,
and various services provided to consumers through the
channels of distribution. The final part of the marketing
mix is the generation of profit for the firm (Hiebing and
Cooper, 1990).
Pricing strategies
Pricing strategy is seen in perspective as one of
several interdependent elements in the marketing mix. The
role of price as a determinant of demand at the expense of
such non-price variables as promotion and distribution is
emphasized by economic theorists. The economic concept of
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pricing generally emphasizes the level of price charged,
overlooking such important marketing considerations as how
prices are paid by consumers.
An organization's pricing objectives are normally
derived from its overall marketing strategy and may change
over time in response to changing conditions, both in the
marketplace and in the firm's own resources. A common trade
off is between short run profits versus sales and market
share targets which may enhance profits in the long run.
Pricing strategies must take into account not only the
response of the ultimate consumer but also the needs and
characteristics of intermediaries in the channels of
distribution. Sufficient margins must be offered at each
level of distribution to make it financially attractive for
the distributor to carry the product (Pappas and Hirschey,
1985).
Pricing strategies may reflect a communications
objective. Many firms cultivate a value for money image and
are anxious to ensure that each item in the line reflects
that image, even if some are only marginally profitable as a
result. Some firms offer one or more loss leaders on a
temporary basis to attract attention to the entire product
line. At the other end of the spectrum are situations in
which the marketer seeks to enhance the quality image of the
product by deliberately charging a relatively high price.
The price of Rogaine reflects the quality image Upjohn wants
to project.
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Prices and pricing strategies a firm implements are
influenced by a number of factors. These include the cost
structure of the firm, and the price elasticity of both
primary and selective demand. The competitive structure of
the industry in which the firm is competing influences the
prices and pricing strategies a firm implements. Finally,
the product characteristics, the availability of supply
relative to demand, and legal considerations contribute to
the firm's pricing strategies (Pappas and Hirschey, 1985).
One area that may be causing customers to hesitate
using Rogaine is the price. The company could gain several
advantages by lowering the price. Some of the advantages of
lowering the price of Rogaine may be that more people would
be willing to try it, and those who are currently patients
would continue treatment. A lower price may strengthen
brand loyalty. Thus, sales may increase which in turn,
would allow Upjohn to further invest in product development
and refinement. Upjohn may be able to penetrate the market
deeply and stimulate long term growth and brand loyalty
enabling it to secure a dominant position in the market
preempting competition and ensuring long run profitability.
Several aspects of an organization's cost structure
need to be considered. The level of variable costs per unit
and the extent to which these are likely to form a high
proportion of selling price influences an organization's
cost structure. The level of fixed costs, the potential for
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economies of scale, and a firm's cost relative to those of
its competitors need to be considered in an organization's
cost structure.
When an organization is operating with high fixed costs
and relatively low variable cost per unit, the incremental
cost of accommodating new customers is comparatively little
in relation to the price charged. Earnings may rise sharply
if sales increase. Capital intensive organizations are
termed volume sensitive. Upjohn is a capital intensive
.organization which desires to sell high volumes of Rogaine
at a high price to recover the costs of research and
development, marketing, distribution, and to capitalize on
the uniqueness Rogaine offers.
The reverse may also be true. Fixed costs may be
comparatively low and variable costs per unit fairly high.
Competition tends to force the price down, unit contribution
is often low and even substantial increases in sales volume
may not improve earnings by a large dollar amount. An
increase in price may have a significant impact on dollar
earnings. In such instances, profitability is said to be
price sensitive.
A key factor influencing pricing decisions is the
sensitivity of demand for the product in question to changes
in the selling price. If demand rises (falls) sharply when
the price is lowered (increased), then demand is said to be
highly elastic because it is responsive to changes in price.
If demand is little affected by price changes, it is said to
be inelastic (Pappas and Hirscpey, 1985). An example of
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inelastic demand is the demand for electricity. If the
price of electricity goes up (down) the demand is little
affected since people need electricity regardless of the
price. Conservative measures will be taken when the price
of electricity increases however, the demand will remain
relatively constant with price changes. The demand for
Rogaine is elastic. This determination of elasticity for
the demand of Rogaine is based on the results of the survey
conducted by the researcher in Milwaukee County. More
potential patients may try and may continue to use Rogaine
if the price was lower. In all of the responses from the
survey that was conducted in Milwaukee County by the
researcher, both the physicians and the general public
indicated that the price of Rogaine was too high.
The price sensitivity of demand for a particular
product category reflects the importance of the product for
consumers. The income level of present consumers, the
existence of substitute products, and the extent to which
potential exists for increasing consumption influence the
price sensitivity of demand for a product. The price
sensitivity of demand is also reflected by whether or not
the product in question is merely a small component in a
much larger entity (Pappas and Hirschey, 1985). The price
sensitivity of demand for Rogaine is high. The product is
highly important to current and potential customers because
it is the only effective product of its kind that is FDA
approved for the treatment of male pattern baldness. No
substitutes exist, therefore Upjohn demands a high price.
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The high price and the life time usage Rogaine requires
limits the product to those with high levels of income.
Thus, the wealthy are able to continue the future
consumption of Rogaine provided they are appropriate
candidates and are pleased with the results of.
The price elasticity for a particular product category
is not necessarily constant but varies between different
price levels and also over time. A marketing manager may
also find that, although some price changes have little
immediate effect on demand, clear trends become apparent
later (Pappas and Hirschey, 1985). This is particularly
true with Rogaine since the product requires life long use.
If the price went down, perhaps more men would use Rogaine.
The number of firms in an industry have a direct effect
on pricing policy. When many competitors are selling an
undifferentiated product, individual marketers have little
discretionary power to influence the prices at which they
sell. In the absence of government regulation or the
presence of a cartel, price is set by free market conditions
and the marketers have little option but to accept it.
At the other extreme are those marketers who have no
direct competition for a needed product. In theory,
monopolists have complete discretionary power to establish
their own selling price. However, in practice, government
regulatory bodies often set the rate structure which the
company has to accept. Even when no regulations exist, many
monopolists choose not to set a price that would maximize
profit, either for ethical reasons or for fear of attracting
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new regulatory controls or new competitors. Rogaine is a
highly differentiated product, it is the only hair treatment
with FDA approval. The FDA regulation which banned any non
prescription treatment claiming to grow hair eliminated any
immediate competition in the United states. The time and
testing it takes to attain FDA approval eliminates the rest
of the current competition in the United states.
In oligopolistic situations, where there are relatively
few competitors, it is common to find one or two of the
principal firms as price leaders (Pappas and Hirschey,
1985). Other firms are often content to follow this lead,
settling for a stable market in return for an acceptable
margin of profit. Although the industry leaders have some
discretionary influence over the selling price in such
situations, they risk losing this role if their own price
strays too far from those dictated by underlying supply and
demand forces in the industry.
As well as evaluating the nature and extent of existing
competition, a marketing manager must also be aware of
potential entrants to the industry before establishing a
pricing policy. If barriers to entry are high due to the
need for substantial capital investments and/or access to
scarce resources or expertise, then the prospect of new
entrants may be remote. The barriers to enter the market
and compete directly with Rogaine are high due to the
testing and research needed for FDA approval and the
attainment of a patent that protects Rogaine. However, the
high price and high earnings within an industry may attract
34
new competitors who are prepared to make the necessary
investment for entry. Several United States firms have
recognized Rogaine's success for treating' male pattern
baldness and are developing similar products that will
compete with Rogaine in the future. Many firms in
oligopolistic industries adopt a low price, preferring low
earnings now to the prospect of additional competitors in
the future. If the price of Rogaine is lowered
significantly it may attract more customers to try it.
Many firms attempt to escape from the constraints that
industry structure imposes on pricing policy by
differentiating other elements of the marketing mix.
Analysis of competitive offerings, distribution channels,
and consumer needs provide insights into the extent to which
such differentiation is both realistic and feasible.
Pricing policies are said to be discriminatory when a firm
sells the same product at a different price to different
buyers who are competing with one another. It is not
discriminatory for a marketer to sell to a wholesaler and to
a retailer at a different price, since the two are not in
direct competition. The law only allows price
discrimination in certain circumstances, such as meeting the
price of a competitor in good faith or when the price
differential is cost justified (Kempin and Wiesen, 1983).
In establishing the price of a new product, the
characteristics of the product itself play a central role.
If it is merely a "me-too" item not strongly differentiated
from competitive offerings, then the level of existing
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prices may provide the crucial determinant. Greater price
discretion may be available to the marketer of a
distinctively different product which has no close
substitutes and is unlikely to be imitated in the short
term. Rogaine is an example where Upjohn has greater price
discretion.
Other inputs to the pricing decision include an
analysis of the market, prospective consumer segments,
existing or potential competitors, and the needs of the
trade. Management must estimate the potential volume of
demand in each major segment and the speed with which this
demand would develop. These may be sensitive to changes in
both the price and the level of marketing effort. A new
product may be tested at a different price in matched cities
in order to obtain a better feel for the sensitivity of
demand to these variables. An evaluation of competitive
activity, if any, would provide details of the competitor's
price range and the terms they offer the trade. It may also
help the marketer evaluate the possibility of price
retaliation by firms marketing products likely to be
displaced by the newcomer (Greyser, 1972).
By reviewing all these pricing factors and undertaking
a sensitivity analysis of the economic implications of
alternative strategies, a marketing manager may be able to
select and implement the correct pricing policy. One type
of pricing policy is skimming the market with a high initial
price. The other type of pricing policy is penetrating the
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price. The other type of pricing policy is penetrating the
market with a low price to stimulate market growth (Pappas
and Hirschey, 1985).
Skimming is usually limited to distinctively different
products (Kolter, 1988). It involves setting a high
initial price which skims the "cream of demand" at the
outset, yielding a high profit during the period before
competition enters the market and the price starts to fall.
A high initial price is sometimes employed as a means of
restricting demand at the outset when supplies of the
product are limited. Market penetration is the opposite
approach. It involves use of low price to stimulate market
growth and enable the firm to gain a dominant position,
hopefully preempting competition and ensuring long run
profitability.
As the product matures and competitive activity
increases, periodic evaluation is necessary to ensure that
the pricing policy is realistic in the light of market
conditions and the objectives of the firm. Upjohn is
clearly skimming the market with a high price since Rogaine
is truly a distinctive product with no immediate
competition. The price may be based on the effectiveness of
Rogaine, especially the long term test results of
effectiveness, the market of potential users, and the long
term use the product reqUires. Skimming is a short term
philosophy based on exploiting the market before competition
enters. The high barriers of entry are based on the FDA
banning any treatment that claims to grow hair and the
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testing required to attain FDA approval. Market penetration
will focus on the key issue of the life long use Rogaine
requires. Low price may encourage patients to continue
treatment and stimulate long term market growth and
profitability.
Even though Rogaine's current price average of $45 per
month is attracting business ($48 million in sales in 1988)
the price is not encouraging long term use (Eaton, 1989).
Reviewing the prices that were charged for competing
.cosmetic hair treatment products prior to the FDA banning of
such products, the average market price was $30 per month.
These products did not give the results Rogaine did, yet
yielded $1 billion in sales in 1988 (Rhein, 1988). If the
price range of Rogaine fell between 25 percent and 35
percent the product would sell for $33.75 and $29.25 per
month respectively and may be more affordable for life long
use.
The initial and follow up visits to the physician must
also be considered in the cost of Rogaine treatment. The
visits to the physician could add $25 to $35 to the cost of
the trial usage of Rogaine. In addition to the cost of the
visits the time and inconvenience of the visits could be
perceived as costs by the potential customer.
Although there are advantages of having a product at a
low price there are also disadvantages of offering a product
at a low price. Some of the disadvantages of offering a
product at a low price include jeopardizing the product
quality image Upjohn has. A product offered at a low price
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might give customers the impression that Upjohn is a budget
priced operation and quality is being sacrificed. Finally,
depending on the extent of the price reduction, short term
profits may be sacrificed if the price is lowered.
Sales Promotions
Rather than lower the price of Rogaine, Upjohn could
implement a sales promotion marketing strategy. Sales
promotions are another marketing strategy Upjohn could use
to attract more business to Rogaine which would help
overcome the resistance patients have to the high price.
Sales promotions that would be applicable to Rogaine include
coupons, cash refunds, patronage rewards, and tie in
promotions. These promotions combined with advertising
would further prompt potential patients to try Rogaine and
would encourage current users to continue treatment.
Sales promotions provide added incentive, encouraging
the target market to purchase the product. The results of
sales promotions are either increased short-term sales
and/or an association with another product. An example of
this is product sponsorship of special events.
Sales promotion is the only marketing mix tool for
which the marketer develops specific sales objectives. A
sales objective is the dollar amount that is to be attained
in a specified period of time. A sales promotion is both
exclusively short term in nature and affects customer
behavior. Customer behavior is affected through tangible
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incentives, resulting in incremental sales generation and/or
an incremental association with the product (Hiebing and
Cooper, 1990).
A closed promotion, coupons for example, may give
consumers an added incentive to purchase. They are required
to do something in order to take advantage of the offer.
Coupons are certificates entitling the bearer to a stated
savings on the purchase of the product. Coupons are heavily
used in consumer products such as soap and paper products.
Two thirds of American consumers use coupons in their
regular shopping (Freeman, 1989). Since Rogaine is a
prescribed personal hair care treatment, it could be
considered a consumer product. Coupons would allow users to
immediately experience the savings at the time of purchase.
Coupons could be included in the information pack that
Upjohn sends to prospects who called the toll free number
requesting further information on Rogaine. Coupons could
also be included in magazine and newspaper advertisements.
Cash refunds or rebates are like coupons except that the
price reduction occurs after the purchase rather than
before. Cash refunds make the consumer take action to get
the money back. The interaction between the consumer and
the company in cash refunds helps focus the attention of the
consumer on the product.
Patronage rewards are values in cash that recognize
one's extended use of the product. Since Rogaine requires
life long use, Upjohn could recognize and congratulate those
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who continue to use the product through financial rewards.
This could help promote future use of Rogaine.
Tie in promotions couple two or more related products
together through the use of coupons and refunds. Rogaine
could be tied in with men's shampoo or other hair care
products for men. Rogaine could team up with a highly
recognized men's hair care product which would increase its
exposure to new users and enforce the advertising campaign.
Promotions can be delivered by three basic methods.
The first vehicle of delivery of coupons is through the
media. Direct mail to the target market, magazines that the
target market reads, and newspapers are the most common
media delivery methods for packaged goods.
A second means of delivery of coupons is on or 1n the
package itself. Coupons on or 1n the package will encourage
future purchases and make it easy for the consumer to attain
the coupon. Coupons on or in the package could also
encourage the consumer to purchase other products offered by
the company.
Sales people through in person selling contact with
pharmacists are the third channel of delivery of coupons.
Sales people can leave coupons with the pharmacist who in
turn forwards them to the consumer (Hiebing and Cooper,
1990). Through the personal sales contact with the
pharmacist the sales person can immediately follow up on
which product is selling quickly and replenish coupons for
the pharmacist.
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Expenses must be projected for each promotion.
Included should be all costs associated with communicating
and delivering the promotion to the target market. This
includes media costs associated with delivering the
promotion. The cost of the offer must also be estimated.
For example, if ten dollar coupons are to be used, the
redemption number along with the handling costs must be
calculated to determine the cost of the coupon incentive.
The value of the coupon and the number of coupons
distributed are variables that need to be calculated in the
cost of a coupon promotion. Also included in the
calculation are the estimated redemption rate, the number of
coupons redeemed, and the dollar value of the coupon. The
advertising and media costs which include the printing and
the mailing of the coupons if direct mail is being used are
the final components used in calculating the cost of the
coupon promotion (Kolter, 1988).
Before a promotion is implemented a payback analysis
must be done. The calculation of the gross margin to net
sales isolates the promotion and takes into account any
incremental variable costs associated with the promotion.
In using this method, incremental costs of the promotion
which include communication of the promotion and incentive
costs are subtracted from incremental sales generated from
the promotion (Hiebing and Cooper, 1990).
The promotion must stand on its own. The only way to
determine its potential success or failure is to weigh the
projected incremental sales against the expected incremental
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expenses of the promotion (Hiebing and Cooper, 1990). If
the promotion contributed a meaningful positive dollar
figure to fixed overhead and meets the promotional sales
goals, then the p~omotion should be executed. Fixed
overhead are expenses that occur no matter what happens. An
example of fixed overhead is rent. If the payback analysis
shows that there is a negative contribution to fixed
overhead, then another promotion should be considered or the
current promotion must be reworked with less incentive or a
different product mix (Hiebing and Cooper, 1990). If the
firm is trying to gain trial usage or purchase of the
product and has set no budget parameters specifying what the
promotion must contribute to profits, then the firm may
believe the promotion will translate into future profits.
In order to do an accurate payback calculation for an
open promotion of Rogaine, more data is needed. This needed
data is not available to the researcher. Thus, the
researcher is not able to illustrate a payback calculation
in an appendix. Included in the needed data is the type of
promotion selected, the geographic location where the
promotion is to be conducted, and the estimated sales from
the promotion. The gross margin dollars that the firms
chooses to sell the product at, and the media and
advertising costs that the firm is currently spending
without the promotion and anticipates to spend with the
promotion is data that is also needed. Finally, Rogaine's
contribution to fixed overhead is needed to accurately
calculate the payback of an open promotion.
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The next step is choosing the correct promotion. The
marketer must make sure the promotions that are chosen
complement each other and work together through the yea~.
The best method to determine if the promotions properly
interface with each other is to list the promotion in
calender form according to when they will be executed. This
will allow the marketer to make judgement on whether the
promotions selected complement each other based on scheduled
run dates and the types of promotions selected (Hiebing and
Cooper, 1990).
The final step is to develop a long term promotion
program. One method of incorporating promotions into a long
term plan is through a trial-to-loyalty promotion program.
This is a method by which a marketer can take the consumer
through successive steps from trial purchase to repeat
buying by using a disciplined promotional program. With
eacn step the consumer is asked to perform a stronger
behavior and is given less reinforcement to purchase the
product, until finally, purchase is at full price and the
consumer is a brand loyal, long term customer.
The trial-to-loyalty promotion occurs by using primary
reinforcers to stimulate initial trial purchase and
secondary reinforcers to encourage repeat purchase. The
primary reinforcers provide strong promotional incentives
while the secondary reinforcers have weaker incentive
properties. In order for the marketer to attract new
customers there is usually a need for greater incentives to
initiate trial purchase or use. However, once the customer
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has tried the product, each successive purchase should be
more and more due to the product's attributes rather than
the incentive, until finally the customer purchases at full
price because of the product's attributes.
Thus, there is need to educate the consumer during the
initial stages on why the product is superior or is
consistent with the image the consumer wants to portray.
Education is achieved within the promotion communication.
The three stages of trial-to-loyalty promotion include:
"trial stage, brand conscious stage, and loyalty stage.
In order for the trial stage to be implemented for
Rogaine the customer must first visit a physician since it
is a prescription drug. After an examination the physician
should know if the customer is a potential candidate to use
the drug. If so, the physician could give the customer a
sample of Rogaine to try along with a half price coupon for
the next purchase. In doing this, trial usage is encouraged
with no commitment from the consumer with the exception of
visiting the physician. Repeat purchase is encouraged;
however, there is a large inducement so the consumer does
not have to commit fully to purchase but is essentially
subsidized by the company.
The second step is the brand conscious stage. This is
achieved by utilizing the secondary reinforcer of proof of
purchase premiums or refunds. The consumer is asked to
purchase the product at full price prior to receiving a
reinforcer in the form of a refund or premium. The consumer
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purchases the product at full price for its inherent value
with the promise of a future reward.
The use of sweepstakes to communicate the product's
attributes and benefits is another step to build brand
consciousness. An example of a sweepstakes would be having
customers answer questions about the product that can be
found on the product's package. This makes each customer
pick up the package, think about the product's name, and
answer questions about the product's benefits. Correctly
answering the questions would qualify the customer for a
drawing to determine the winner.
The final step is the loyalty stage. The customer is
fully convinced by the product. Future purchases by the
customer are at full price.
Upjohn could use sales promotions to increase sales of
Rogaine. The advantages of using promotions include
increasing consumer's awareness of the product, and
complementing advertising. Sales promotions will make the
consumer more active in the purchasing process. Rogaine
could attain an image of a consumer product rather than an
intimidating pharmaceutical product through the use of sales
promotions.
Although sales promotions are attractive to increase
sales they do have disadvantages. The disadvantages of
using promotions would be the increased cost of marketing,
and coordinating marketing efforts. The use of sales
promotions may entail giving up complete marketing control,
and sharing profit margin with an outside source. This could
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be exemplified when a firm utilizes and advertising agency.
The advertising agency is employed by the firm that is
marketing a product. Therefore, the complete marketing
control is being given up.
A final disadvantage of sales promotions is that the
company must have full confidence in the effectiveness of
the product. The company must believe that customers will
continue to purchase the product at full price in the
future. Otherwise the company is taking a great financial
risk by using refunds, free samples, and coupons.
Upjohn currently uses cash refunds and coupons as part
of its sales promotion campaign. A ten dollar cash refund
is given when a customer visits a physician for hair
consultation. The customer brings the certificate to the
office visit with the physician. The physician signs it and
the customer sends the certificate to Upjohn. If the
physician prescribes Rogaine the customer receives (four)
five dollar coupons that can be used towards the first
(four) months of treatment. Potential customers learn of
this sales promotion campaign only when they call Upjohn via
the toll free number listed on television and print
advertisements. In order for Upjohn to fully utilize the
use of sales promotion the advertisements should mention to
the potential customer that promotions are available.
Advertising
Along with the usage of sales promotions the
advertising that Upjohn uses for Rogaine is a soft sell
television and print campaign that urges consumers to "see
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your doctor if you are concerned about hair loss". In order
to sell the product, advertising must first attract the
attention of customers. The soft sell, suggestive approach
may be vague to some viewers who do not know if Upjohn is
advertising a procedure like hair transplants or a hair
treatment. The advertisements conclude with the Upjohn
corporate logo. Upjohn refers prospective patients to
physicians for two reasons. First, Rogaine is a prescription
pharmaceutical that could only be attained through a
physician. Second, going through doctors was a good way to
overcome the credibility hurdle that was erected by past
false advertisements of baldness treatments. The target
market must have a positive attitude toward what the company
is selling. The television advertisements, which reach most
prospective users, do not mention the brand name Rogaine.
The reason for this is because United States federal
regulations require data on side effects and other
information to be mentioned in the advertisements since
Rogaine is a prescribed pharmaceutical product. However,
the print advertisements do mention the brand name Rogaine
along with the side effects. They may not reach as many
viewers as the television advertisements.
The usage of sales promotions must be mentioned along
with clear advertisements in Upjohn's advertising campaign.
Viewers of the advertisements could have a better
understanding of the message Upjohn is communicating if the
brand name Rogaine and specific testimonial results are
used. The viewers will know what results can be expected
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from the product rather than only know the name of the
manufacturer and a toll free number to call.
Precise, attention getting advertisements have
several advantages. They communicate exactly what the
product is, what it does, what the name of the product is,
and how the customer may benefit from its use. The results
to the company may be increased sales. Even if the brand
name is not mentioned, harder sell advertisements could help
make the concept of the product clear and concise.
There are disadvantages to mentioning the brand name
Rogaine on television advertisements. Since the law
requires the mention of side effects prospective patients
may choose not to use the product. Finally, the listing of
the side effects might make the advertisements too
complicated, long, and more expensive.
Alternative Two - Start a Joint Venture The Upjohn
Pharmaceutical Company is highly respected and recognized in
the pharmaceutical industry. When Rogaine was first
introduced Upjohn marketed the product like the rest of its
pharmaceutical line. The company chose a soft sell
advertising campaign and concentrated on the medical side
through sales representatives informing physicians of the
product. Rogaine is a unique product in that it is a
pharmaceutical that needs to be marketed like a personal
product for men. Upjohn has confronted a marketing dilemma.
It does not have marketing experience or channels of
distribution for personal products for men nor is its name
recognized within the industry for personal products for
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men. A possible solution to this marketing dilemma could be
to start a joint venture with a company that is established
and recognized in the personal products for men industry.
In joint ventures, two or more companies create a
business in which they share joint ownership and control.
Either company may buy an interest in an existing operation.
Two or more parties may also form a new business venture.
An example of a company that has personal products for
men which Upjohn could form a joint venture with would be
Gillette. Gillette is a highly recognized, established
company that sells personal products for men. It mass
merchandises its products in department stores and drug
stores. Gillette extensively advertises on television and in
the print media.
Gillette could develop products that would complement
the use of Rogaine such as special shampoos and conditioners
that promote a healthy scalp for balding men. This would
take advantage of the fashion image, name, marketing and
advertising techniques Gillette offers. The mass
merchandising and distribution channels of Gillette are
better able to exploit the hair treatment market from the
consumer side rather than through the medical side. The
joint venture could use the Upjohn name and the FDA approval
of Rogaine to increase the legitimacy and results the
product offered. Both Gillette and Upjohn would benefit in
that the complementing products would attract attention to
and expand Gillette's product line. The joint venture would
allow Gillette to demonstrate its marketing techniques,
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techniques that Upjohn presently lacks. Upjohn could then
concentrate its research and development efforts on
pharmaceuticals and on the improvement of Rogaine.
The disadvantages of a joint venture include sharing the
revenue and control with another company. There may be
disagreements on marketing and investment policy
philosophies. Since Rogaine is a prescription drug it can
only be sold through pharmacies. Thus, the selling of
Rogaine in a fashionable department store is not possible.
To conclude, a joint venture offers many advantages to
Upjohn and to Gillette. Gillette offers access to channels
of distribution otherwise not available to Upjohn. Gillette
has a name synonymous with personal products for men. This
name could help Upjohn attain recognition in the personal
products for men market. Gillette could benefit by having
its product line expanded.
Alternative Three - Abandon Rogaine ~~pjohn had spent
$60 million in 1989 on the advertising campaign of Rogaine
yet the product returned only $48 million in sales in 1988.
Based on this $12 million loss, Rogaine is losing money for
Upjohn. The abandonment of Rogaine would allow Upjohn to
cut its losses and concentrate on an area it knew best, the
research and development of high quality, effective
pharmaceuticals.
Upjohn does not have experience marketing personal hair
products for men. Upjohn's experience lies in informing the
physicians and health care professionals of its
pharmaceutical products.
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Although the response to the Milwaukee County survey
was low and the results are not conclusive, it appears the
Milwaukee market for Rogaine is rather limited. Those who
are young, rich, and healthy are good candidates for Rogaine
treatment. The ideal candidate for Rogaine also has a
specific type of male pattern baldness, along with a high
level of patience for the slow, limited results Rogaine
gives. Finally, the ideal candidate will comply with the
requirement of applying Rogaine twice a day for the rest of
'his life.
The present chairman of Upjohn appears to be closely
involved with Rogaine. He believes that Upjohn has finally
found the ultimate treatment for male pattern baldness. The
company is optimistic about Rogaine becoming a leading
product in the pharmaceutical industry.
Abandoning Rogaine is an option available to Upjohn.
There are several advantages to this option. Abandoning
Rogaine will save money and time which could be put in more
profitable areas of the company. The product may hamper
growth opportunities ·and consume the time of the marketing,
research and development, sales, and customer relations
staff.
There are disadvantages associated with the abandonment
of Rogaine. These disadvantages include the loss of money
and time that was spent researching and marketing Rogaine.
If Upjohn abandons Rogaine another company with more
effective marketing methods could gain from the foundation
Upjohn established. Those who tried Rogaine and were
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discouraged by the high cost and limited results may develop
negative feelings toward the company and may choose not to
buy Upjohn products in the future. Researchers may not turn
to Upjohn to help market and develop innovative products in
new industries.
Recommendation
The researcher recommends the implementation of
alternative one which includes strategic pricing strategies,
more precise advertising and the use of sales promotions.
This may be the best long term solution to the marketing
problem Upjohn has with Rogaine. These three marketing
strategies give the firm diverse avenues to catch the
attention of and retain customers.
The demand for Rogaine may rise if the price is
lowered. This price elasticity of demand is affecting the
sale of Rogaine greatly. Based on the survey conducted by
the researcher in the Milwaukee County market, both the
physicians and the general public indicated that the price
of Rogaine was too high. The response to the two surveys in
Milwaukee was low thus the results are not conclusive. A
lower price may help Upjohn penetrate the market. Through a
lower price customers may become loyal users of Rogaine
enabling it to secure a· dominant position in the market
preempting competition and ensuring long run profitability.
Sales promotions may help overcome the resistance
patients have to the price. Patronage rewards could
recognize and congratulate customers for continuing to use
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the customer participation sales
consciousness of Rogaine may





Sales promotions complement advertising helping the
consumer to be more aware of the product. Sales promotions
also make the consumer more active in the purchasing
process. This increased activity of the consumer could help
Rogaine attain an image of a personal product for men rather
than an intimidating pharmaceutical product. Promotions
that complement advertising along with an increased consumer
awareness and activity could help Upjohn increase the sales
of Rogaine.
Finally, harder sell advertising that communicates the
specifics of the product may help Upjohn increase sales of
Rogaine. The customer must understand more about the product
Upjohn is trying to sell. The researcher suggests that the
implementation of alternative one may help Upjohn increase
the sales of Rogaine •.
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Appendix A
One Months Supply of Rogaine




Example of Daily Application of Rogaine
Source: The Upjohn Company
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Rogaine Topical Solution is applied to the scalp twice a day. Physicians stress that
treatment must be maintained faithfully over a minimum four month period before








Are you aware of the Upjohn Company's hair treatment drug
Rogaine?
YES _ NO _
What is your overall impression on a one (disapprove) to ten
(approve) scale of the drug as far as its effectiveness
verses other alternatives such as hair weaving and scalp
reduction?
1 2 3 4 5 6 7 8 9 10
Have you recommended Rogaine?
If so, why?
If not, why not?
If you have recommended Rogaine, was it beneficial?
YES _
Why was it not beneficial?
NO _
Have more patients been coming to you as a result of seeing
advertising on Rogaine?
What is the average age of the patient on R~gaine?
How do you feel about the risks verses the results of
Rogaine?
What do you think of the continuous long term use of
Rogaine?
What do you think of the price of Rogaine?
In your opinion, what would be a fair price for Rogaine?
How would you rate the results of Rogaine on a one
(disapprove) to ten (approve) scale?
1 2 3 4 5 6 7 8 9 10
How many patients do you have that you prescribed Rogaine
to?
Appendix D
Questionnaire to Potential Customers




How old are you?
Are you married?
Have you ever considered treatment for hair loss?
Are you familiar with the hair treatment the Upjohn Company
has namely Rogaine?
Have you seen any advertising for the drug Rogaine?
If so, where did you see the advertising?
What did you think of the advertising?
What changes in the advertising do you think should be done?
Do you know anyone who is using Rogaine?
If so, what do you think of the results?
Have the people you know that are using Rogaine suggest that
you try treatment?
What do you think of daily, long term use of a product that
will help reduce the balding effect?
What would you be willing to spend on a hair treatment that
would reduce or even stop the balding effect?
$45 $50 $60 $65 $70 $80 per month
If you are currently a user of Rogaine, what recommendations
do you have that would make you more satisfied with the
treatment process from the initial doctor visit, the cost,
the promotions, the daily use of the product.
Appendix E
The Impression the Physicians That









~: 4.00, Mean: 4.25, Median: 5.50, Variance: 1.94
1dard Deviation: 1.39
~nd: Y axis = number of physicians who responded to the survey.
X axis = physicians overall impression of Rogaine on a one
(disapprove) to ten (approve) scale.
Appendix F
The Increase in Men That Were Coming to























Total population of physicians surveyed: 132
35 Responses (27 percent response)
97 Non responses (73 percent non response)
70 percent of the physicians that responded to the survey indicated
increase in patient interest.
30 percent of the physicians that responded to the indicated a
decrease in patient interest.
Legend: Y axis = number of physicians that responded to
survey.
X axis = response to the question asked to
physicians that responded to the survey: Are more
patients coming to you as a result of seeing
advertising on Rogaine.
Appendix G
Relation Between the Men That Responded to The








































































Average age (mean): 32, Median age:
(Bimodal)




Total population of 200 men surveyed. 81 respondents completed
survey (41 percent response). 11 men started survey but
ended (six percent response). 108 non respondents (53 percent
non response rate).
Legend: Y axis = percentage of men that responded to
the survey who would use Rogaine.
X axis = age brackets of men that responded to the
survey.
Appendix H
Relation Between the Hen That Responded to the
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Married
72
44 percent of overall respondents were married.
56 percent of overall respondents were single.
58 percent of respondents who would use Rogaine were sin
gle.
79 percent of respondents who would use Rogaine were sin
gle.
Legend: Y axis = Percentage of men who responded to th
e
survey that would use Rogaine.
X axis = Marital status of men who responded to
the survey.
